Elevation Oncology (ELEV) SEC Filings & 10K Form

$3.72
-0.01 (-0.27%)
(As of 09:45 AM ET)

Recent Elevation Oncology SEC Filings

DateFilerForm TypeView
05/09/2024
11:15 PM
Elevation Oncology (Filer)
Form EFFECT
05/02/2024
7:01 AM
Elevation Oncology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/02/2024
6:47 AM
Elevation Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
6:01 AM
Elevation Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
3:25 PM
Elevation Oncology (Filer)
Form ARS
04/26/2024
3:20 PM
Elevation Oncology (Filer)
Form DEFA14A
04/26/2024
3:15 PM
Elevation Oncology (Filer)
Form DEF 14A
04/09/2024
3:26 PM
Elevation Oncology (Subject)
Frazier Life Sciences Public Fund, L.P. (Filed by)
Form SC 13G
04/05/2024
3:15 PM
Elevation Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
7:14 AM
Elevation Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/06/2024
6:45 AM
Elevation Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
6:00 AM
Elevation Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/04/2024
3:40 PM
Elevation Oncology (Issuer)
Sandler Alan B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
3:28 PM
Cherrington Julie M (Reporting)
Elevation Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
3:16 PM
Cherrington Julie M (Reporting)
Elevation Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/04/2024
3:21 PM
Elevation Oncology (Issuer)
Sandler Alan B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/20/2024
3:48 PM
Elevation Oncology (Issuer)
Ferra Joseph J Jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:42 PM
Elevation Oncology (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G
02/14/2024
3:45 PM
Elevation Oncology (Subject)
K2 HealthVentures Equity Trust LLC (Filed by)
Form SC 13G/A
01/31/2024
3:32 PM
Elevation Oncology (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G/A
01/23/2024
3:15 PM
Elevation Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2024
3:57 PM
Elevation Oncology (Subject)
Logos Global Management LP (Filed by)
Form SC 13G
01/22/2024
3:35 PM
Elevation Oncology (Issuer)
Mootz Darcy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
3:24 PM
Elevation Oncology (Issuer)
Mootz Darcy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/22/2024
8:02 AM
Elevation Oncology (Subject)
Farallon Capital Partners, L.P. (Filed by)
Form SC 13G
01/22/2024
6:45 AM
Elevation Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
3:24 PM
Elevation Oncology (Subject)
Qiming U.S. Healthcare GP II, LLC (Filed by)
Form SC 13G/A
01/09/2024
8:07 AM
Elevation Oncology (Subject)
Empery Asset Management, LP (Filed by)
Form SC 13G
01/05/2024
6:40 AM
Elevation Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
6:45 AM
Elevation Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
6:00 AM
Elevation Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/22/2023
3:30 PM
Elevation Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2023
3:15 PM
Elevation Oncology (Issuer)
Ferra Joseph J Jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
3:42 PM
CLACKSON TIMOTHY P (Reporting)
Elevation Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
6:45 AM
Elevation Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
6:01 AM
Elevation Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/03/2023
6:15 AM
Elevation Oncology (Filer)
Form 424B5
08/03/2023
6:45 AM
Elevation Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2023
3:29 PM
Elevation Oncology (Issuer)
Furlong Tammy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2023
3:26 PM
Elevation Oncology (Issuer)
Furlong Tammy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/14/2023
3:17 PM
Elevation Oncology (Issuer)
Ferra Joseph J Jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (Ad)

The AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016.

Get the full story here.
07/13/2023
7:15 AM
Elevation Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
3:12 PM
CLACKSON TIMOTHY P (Reporting)
Elevation Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
3:13 PM
Elevation Oncology (Issuer)
Hu Lori (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
3:15 PM
Elevation Oncology (Issuer)
Walsh Colin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
3:06 PM
Elevation Oncology (Issuer)
Ferra Joseph J Jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:15 PM
Elevation Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2023
3:30 PM
Elevation Oncology (Subject)
venBio Global Strategic Fund III, L.P. (Filed by)
Form SC 13D/A
06/08/2023
3:30 PM
Elevation Oncology (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G
06/05/2023
6:00 AM
Elevation Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2023
4:15 PM
Elevation Oncology (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ELEV) was last updated on 5/16/2024 by MarketBeat.com Staff

From Our Partners